Peter R. Hoffmann, PhD, MSPH

Peter R. Hoffmann, PhD, MSPH

This email address is being protected from spambots. You need JavaScript enabled to view it. | (808) 692-1510

Full Member, Cancer Biology Program, University of Hawaiʻi Cancer Center

Academic Appointment(s):
Professor, Cell and Molecular Biology Department, John A. Burns School of Medicine, University of Hawaiʻi at Mānoa

Degree(s):
PhD, Immunology and Microbiology, University of Colorado Health Science Center
MSPH, Public Health, University of Hawaiʻi at Mānoa

Research Focus

Our research is focused on identifying mechanisms by which inflammation and immune responses are regulated. Our recent work identified the endogenous inhibitor of calpain enzymes, calpastatin, as a protein upregulated in human IBD tissues as well as chronically inflamed colon tissue in mice subjected to dextran sulfate sodium (DSS)-induced colitis. The central role of calpastatin in limiting inflammation suggests that intervention with a synthetic calpain-2 inhibitor may assist the endogenous response to inflammation and thereby serve as an effective approach to treating IBD and preventing colorectal cancer. Thus, our goal is to develop calpain-2 inhibitor therapy for treating IBD and preventing the development of colorectal cancer. Other cancer interests involve identifying potential therapeutic targets for treating melanoma, and on-going pre-clinical studies have successfully generated a promising candidate, selenoprotein K, which will be further investigated.

Selected Publications

Fredericks GJ, Hoffmann FW, Rose AH, Osterheld H, Hess FM, Mercier F, Hoffmann PR. (2014). Stable expression and function of the inositol 1,4,5-triphosphate receptor requires palmitoylation by a DHHC6/Selenoprotein K complex. Proc Natl Acad Sci, Nov 18; 111 (46):16478-16483.

Rose AH, Bertino P, Hoffmann FW, Guadino G, Carbone M, Hoffmann PR. (2014). Increasing dietary selenium elevates reducing capacity and ERK activation associated with accelerated progression of select mesothelioma tumors. Am J Pathol, Apr, 184:1041.

Youngren SR, Tekade RK, Gustilo B, Hoffmann PR, Chougule MB. (2013). STAT-6 siRNA Encapsulated Nanocarriers: Formulation, Characterization, and Ex-vivo Proof of Concept using an Adenocarcinomic Cell Line. Biomed Res Int, 2013:858946.

Huang Z, Rose AH, Hoffmann FW, Hashimoto AS, Bertino P, Denk T, Takano J, Iwata N, Saido TC, Hoffmann PR. (2013). Calpastatin prevents NF-B mediated hyperactivation of macrophages and attenuates colitis. J Immunol, Oct 1;191(7):3778-88.

Bertino P, Panigada M, Soprana E, Bianchi V, Bertilaccio S, Sanvito F, Rose AH, Yang H, Gaudino G, Hoffmann PR, Siccardi A, Carbone M. (2013). Fowlpox-based survivin vaccination for malignant mesothelioma therapy. Int J Cancer, Aug 1;133(3):612-23.

Publication list via PubMed

Active Grants

P. Hoffman, Principal Investigator
R01 AI089999
NIH/NIAID
Selenoprotein K modulates calcium-dependent signaling in immune cells
The major goal of this project is to determine mechanisms by which selenoprotein K modulates activation of immune cells.
7/01/2015 - 6/30/2020